• Corporate Brochure
  • Corporate Video
  • Gallery
  • News & Updates
AKUMS DRUGS & PHARMACEUTICALS LTD. AKUMS DRUGS & PHARMACEUTICALS LTD. AKUMS DRUGS & PHARMACEUTICALS LTD. AKUMS DRUGS & PHARMACEUTICALS LTD. AKUMS DRUGS & PHARMACEUTICALS LTD. AKUMS DRUGS & PHARMACEUTICALS LTD.
  • Home
  • About Akums
    • Company Profile
    • Formation
    • Mission and Vision
    • Leadership
      • Directors message
      • Leadership Team
    • Business Model
    • Awards and Accolades
    • Business Partners
  • Our Expertise
    • Manufacturing
    • Research & Development
    • Innovations
    • Quality
    • Regulatory
  • Units
    • Plant 1 (Solid Orals)
    • Plant 2 (Oral Liquids)
    • Plant 3 (Injectables)
    • Plant 4 (Hormonals)
    • Plant 5 (Ointment & Cosmetics)
    • Plant 6 (Maxcure Nutravedics Ltd)
    • Plant 7 (Pure and Cure)
    • Plant 8 (Malik Lifesciences)
    • Plant 9 (Pure Cure Guwahati)
    • Plant 10 (Akums Healthcare Ltd (Sidcul Kotdwar))
    • Centralised Stability Centre
  • Corporate Governance
    • Financial Statements
    • Shareholders Meetings
    • Corporate Social Responsibility
    • Environment Health & Safety
    • Disclosures
  • Global Presence
  • Careers
    • Working with us
    • Colors @ Akums
    • Current Openings
    • Events
    • Employee Recognition
    • Trainings
  • Gallery
  • News
    • Akums in News
    • Industry News
    • Blogs
  • Contact Us
  • Home
  • About Akums
    • Company Profile
    • Formation
    • Mission and Vision
    • Leadership
      • Directors message
      • Leadership Team
    • Business Model
    • Awards and Accolades
    • Business Partners
  • Our Expertise
    • Manufacturing
    • Research & Development
    • Innovations
    • Quality
    • Regulatory
  • Units
    • Plant 1 (Solid Orals)
    • Plant 2 (Oral Liquids)
    • Plant 3 (Injectables)
    • Plant 4 (Hormonals)
    • Plant 5 (Ointment & Cosmetics)
    • Plant 6 (Maxcure Nutravedics Ltd)
    • Plant 7 (Pure and Cure)
    • Plant 8 (Malik Lifesciences)
    • Plant 9 (Pure Cure Guwahati)
    • Plant 10 (Akums Healthcare Ltd (Sidcul Kotdwar))
    • Centralised Stability Centre
  • Corporate Governance
    • Financial Statements
    • Shareholders Meetings
    • Corporate Social Responsibility
    • Environment Health & Safety
    • Disclosures
  • Global Presence
  • Careers
    • Working with us
    • Colors @ Akums
    • Current Openings
    • Events
    • Employee Recognition
    • Trainings
  • Gallery
  • News
    • Akums in News
    • Industry News
    • Blogs
  • Contact Us
­
Industry Newsadmin2021-11-24T11:41:30+00:00

Digital Journal(8th Aug 2022) – Cholesterol API Market size is expected to reach a valuation of US$ 269.0 Mn by the end of 2022

Read More

Pharmabiz(22nd June 2022) – Dermatology sector set to boom in the post Covid-19 market

Read More

ETHealthworld(22nd June 2022) – Akums report 30 per cent jump in dermatology drug sales in May’22

Read More

Financial Express(27th June 2022) – Heat, humidity and pollution led to 30 % jump in dermatology drug sales in May this year: Akums Drugs

Read More

Vergexpress(22nd June 2022) – QR codes securing medicines or additional cost burden to the industry?, Health News, ET HealthWorld

Read More

Mint(18th June 2022) – Drug packaging to sport QR code to stop counterfeiting

Read More
  • 1
  • 2
  • 3
  • 4
  • 5

Akums Drugs & Pharmaceuticals Ltd. India is an internationally recognized WHO-GMP certified and one of the leading contract manufacturing pharmaceutical company. Akums has rapidly emerged as the premier integrated pharmaceutical company in India. Its business focus is on manufacturing & marketing of pharmaceutical products along with serving clients across the globe.

Contact Info

Phone: +91 11 4751 1000 / 6904 1000

Mobile: 9999012080

Fax: +91 11 27023256

Email: Enquiry@Akums.net

Web: www.akums.in

Copyright 2023 Akums | All Rights Reserved